-
B655504-1mlBavisant dihydrochloride hydrate (JNJ31001074AAC) is an orally active, potent, brain-penetrating and highly selective antagonist of the histamine H 3 receptor . Bavisant dihydrochloride hydrate can be used for attention-deficit hyperactivity
-
B168290-100mgIrreversible inhibitor of TNF-α-induced IxBα phosphorylation.
-
B168290-10mgIrreversible inhibitor of TNF-α-induced IxBα phosphorylation.
-
B168290-25mgIrreversible inhibitor of TNF-α-induced IxBα phosphorylation.
-
B647155-10mgBAY 2666605 is an orally active PDE3A and PDE3B inhibitor with IC 50 s of 87 nM and 50 nM, respectively. BAY 2666605 is a PDE3A-SLFN12 complex inducer (WO2019025562A1: example 135)In VitroBAY 2666605 (example 135) has anticancer effects, potently
-
B647155-5mgBAY 2666605 is an orally active PDE3A and PDE3B inhibitor with IC 50 s of 87 nM and 50 nM, respectively. BAY 2666605 is a PDE3A-SLFN12 complex inducer (WO2019025562A1: example 135)In VitroBAY 2666605 (example 135) has anticancer effects, potently
-
B654891-1mlBAY 2666605 is an orally active PDE3A and PDE3B inhibitor with IC 50 s of 87 nM and 50 nM, respectively. BAY 2666605 is a PDE3A-SLFN12 complex inducer (WO2019025562A1: example 135)In VitroBAY 2666605 (example 135) has anticancer effects, potently
-
B647593-10mgBAY 41-4109 is a potent inhibitor of human hepatitis B virus ( HBV ) with an IC 50 of 53 nM.In VitroBAY 41-4109 is able to both accelerate and misdirect capsid assembly in vitro . Preformed capsids are stabilized by BAY 41-4109, up to a ratio of one
-
B647593-1mgBAY 41-4109 is a potent inhibitor of human hepatitis B virus ( HBV ) with an IC 50 of 53 nM.In VitroBAY 41-4109 is able to both accelerate and misdirect capsid assembly in vitro . Preformed capsids are stabilized by BAY 41-4109, up to a ratio of one
-
B647593-5mgBAY 41-4109 is a potent inhibitor of human hepatitis B virus ( HBV ) with an IC 50 of 53 nM.In VitroBAY 41-4109 is able to both accelerate and misdirect capsid assembly in vitro . Preformed capsids are stabilized by BAY 41-4109, up to a ratio of one
-
B649727-100mgBay 65-1942 hydrochloride is an ATP-competitive and selective IKKβ inhibitor.In VitroDelivery of Bay 65-1942 prior to ischemia significantly decreases left ventricular infarct size compared with animals receiving vehicle. Compared with sham animals,
-
B649727-10mgBay 65-1942 hydrochloride is an ATP-competitive and selective IKKβ inhibitor.In VitroDelivery of Bay 65-1942 prior to ischemia significantly decreases left ventricular infarct size compared with animals receiving vehicle. Compared with sham animals,